Researchers are excited about Retatrutide , a innovative dual agonist showing promising data in clinical trials for weight management. It works by modulating several hormones : GLP-1 and GIP, that , when activated , help control appetite and enhance metabolism . Initial reports demonstrate noteworthy weight loss and potential benefits for people st